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Abstract
Purpose  To evaluate if adding nanofractures to the footprint of a supraspinatus tear repair would have any effect in the 
outcomes at one-year follow-up.
Methods  Multicentric, triple-blinded, randomized trial with 12-months follow-up. Subjects with isolated symptomatic 
reparable supraspinatus tears smaller than 3 cm and without grade 4 fatty infiltration were included. These were randomized 
to two groups: In the Control group an arthroscopic supraspinatus repair was performed; in the Nanofracture group the foot-
print was additionally prepared with nanofractures (1 mm wide, 9 mm deep microfractures). Clinical evaluation was done 
with Constant score, EQ-5D-3L, and Brief Pain Inventory. The primary outcome was the retear rate in MRI at 12-months 
follow-up. Secondary outcomes were: characteristics of the retear (at the footprint or at the musculotendinous junction) and 
clinical outcomes.
Results Seventy-one subjects were randomized. Two were lost to follow-up, leaving 69 participants available for assess-
ment at 12-months follow-up (33 in the Control group and 36 in the Nanofracture Group). The Nanofracture group had 
lower retear rates than the Control group (7/36 [19.4%] vs 14/33 [42.4%], differences significant, p = 0.038). Retear rates at 
the musculotendinous junction were similar but the Nanofracture group had better tendon healing rates to the bone (34/36 
[94.4%] vs. 24/33 [66.71%], p = 0.014). Clinically both groups had significant improvements, but no differences were found 
between groups.
Conclusion  Adding nanofractures at the footprint during an isolated supraspinatus repair lowers in half the retear rate at 
12-months follow-up. This is due to improved healing at the footprint.
Level of evidence Level I.
Keywords Shoulder arthroscopy · Rotator cuff · Rotator cuff repair · Microfracture · Footprint preparation · Supraspinatus 
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Introduction
Rotator cuff tears are one of the most frequent causes of pain 
and disfunction in the older adult population [13]. Although 
many rotator cuff tears can be dealt conservatively, some of 
them require surgical repair [1]. Despite advances in sur-
gical technique, the retear rates are often over 20% [10]. 
This high incidence of repair failure is due to fundamental 
biological issues related to the difficulty to obtain consist-
ent tendon-to-bone healing and the unstoppable develop-
ment of tendon degeneration [4]. Many efforts have been 
made to increase the chances to attain healing. Mechanical 
advances in repair techniques (using double row or transos-
seous equivalent [TOE] suture configurations) have got only 
limited benefits. Improving the biological environment using 
platelet-rich plasma [11] or stem cells [20] might increase 
the healing rate marginally.
It has been suggested that performing small holes (micro-
fractures/bone marrow stimulation) in the bone footprint 
before repair might allow for an increased local outflow of 
stem cells and other factors that might improve the healing 
rate [5, 18]. Despite these, at least two randomized con-
trolled trials [14, 15] have not found any significant effect on 
cuff healing. It has been suggested that performing deeper 
and thinner holes in the bone (nanofractures) would allow 
for an increased biological response [6] but this is unproven 
clinically.
The objective of this randomized controlled trial was to 
evaluate if adding nanofractures (1 mm wide, 9 mm deep, 
microfractures) at the footprint of a supraspinatus tear repair 
would have any effect in the radiological and clinical out-
comes at one-year follow-up.
Materials and methods
The study was approved by the Institutional Review Board 
of Hospital Universitario Ramón y Cajal (approval number 
222-16, November 22nd 2016). All patients received oral 
and written information about the study and written consent 
was obtained.
Trial design
This was a 2-arm, multicentric, triple-blinded, parallel-
group, pragmatic, randomized, superiority trial with 
12-months follow-up. A total of 71 subjects were rand-
omized either to have nanofractures (microfractures made 
with a special device that makes narrow [1 mm] and long 
[9 mm] holes in the bone footprint) performed immediately 
before arthroscopic supraspinatus tendon repair (Nanofrac-
ture) or not (Control).
Participants
The inclusion criteria were: (1) being 18 years old or older, 
(2) having a symptomatic supraspinatus tear, (3) that the tear 
was repairable to the footprint with at least 90% coverage, 
(3) that the subject was able to understand and consent to 
participate.
The exclusion criteria were: (1) that the size of the 
supraspinatus tendon tear, measured during surgery, was 
larger than 3 cm in either anteroposterior (tear size) or 
mediolateral (tear retraction) direction, (2) that an preop-
erative MRI evaluation (performed at most 3 months before 
the surgery) showed grade 4 fatty infiltration in any rotator 
cuff tendon according to the criteria defined by Goutalier 
et al. [9] and adapted for MRI by Fusch et al. [8], and (3) 
the presence, during surgery or in preoperative MRI, of a 
subscapularis tear that required repair.
Interventions
After an initial assessment for eligibility criteria, the surgeon 
offered the participant to take part in the study. If informed 
consent was obtained, the participants were brought to the 
surgical theatre. The arthroscopic rotator cuff repair was 
performed under general anaesthesia and/or an interscalene 
nerve block. The posterosuperior cuff tear was debrided and 
assessed for tear pattern (according to Davidson and Bur-
khart [7]), size, retraction and reparability. The supraspina-
tus footprint was debrided of soft tissue and the bone sur-
face was gently decorticated with a burr. A biceps tenotomy/
tenodesis, an acromioplasty, or a Mumford procedure were 
performed if deemed necessary. Once the eligibility criteria 
were confirmed, randomization to one of the two treatment 
groups proceeded.
In the control group, a double row or transosseous equiva-
lent repair was performed. In the Nanofracture group the 
repair was performed likewise, but, immediately prior to 
placing the first anchor, the nanofractures were performed 
using a NanoFx Microfracture Instrument (Arthrosurface, 
Franklin, MA, USA). This device is composed of a long 
handle with a curved tip and a 1 mm thick needle. The han-
dle tip was placed perpendicular to the bone surface and 
the needle, driven through the handle, was repeatedly ham-
mered through the bone, making 1 mm thick, 9 mm long 
holes in it. Starting from the articular edge, the nanofractures 
were made, 3–5 mm apart, until the lateral border of the 
debrided footprint was reached, averaging 6–10 holes per 
square centimetre.
Outcomes
The following evaluation tools were used:
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1. Clinical evaluation was performed preoperatively and 
3, 6, and 12 months after surgery using the Constant 
score and the EQ-5D-3L self-rated general health ques-
tionnaire (using both the VAS data and the health index 
calculated using the Time trade-off system adjusted for 
the Spanish population according to Badia et al. [3]).
2. Pain evaluation was performed using questions 3–6 of 
the brief Pain Inventory (that assess verbally pain in a 
0–10 discrete scale) preoperatively, one and 3 weeks and 
2, 3, 6 and 12 months postoperatively.
3. MRI performed preoperatively and 12 months after sur-
gery.
The primary outcome was the retear rate evaluated in 
the 12 months postoperative MRI. The continuity of the 
tendon was assessed using the Sugaya’s classification [17] 
that classifies the integrity of a repaired tendon in a 5 level 
scale, grades 1–3 were considered healed and grades 4 and 
5 were considered to have failed repair (a retear).
The following secondary outcomes were used: (1) Sug-
aya’s grade in the 12 months postoperative MRI. (2) Place 
of the retear of the tendon, either at the footprint or at 
the musculotendinous junction as described by Trantalis 
et al. [19]; (3) pain levels assessed during the first year 
postoperatively, compared to the preoperative levels and 
between groups; and (4) constant score and EQ-5D-3L 
scores assessed during the first year postoperatively, com-
pared to the preoperative levels and between groups.
Randomization and blinding
A random list of numbers was computer generated with 
an allocation rate of 1:1 using block sizes of 6. A set of 96 
sequentially numbered opaque envelopes were prepared 
by a researcher independent from the study. One block of 
6 envelopes was randomly assigned to each team. When 
any team randomized the first 6 subjects a second set was 
assigned to that team. Once the surgeon had evaluated 
arthroscopically the joint, assessed the supraspinatus tear 
for size and reparability and confirmed that the participant 
met all the inclusion criteria and none of the exclusion 
criteria, the envelope was opened by a nurse and shown 
to the surgeon.
During informed consent, the patients were informed 
that they would be blinded to the arm of the study they 
were being assigned to. The surgeon was not blinded to the 
assignation as he had to perform the nanofractures. Clini-
cal assessment of the participants was done by one surgeon 
of each team that was unaware of the group assignment. 
Neither the person assessing the MRI nor the statistician 
making the statistical analysis were aware of the group 
assignment.
Statistical analysis
Sample size calculation was done using the primary out-
come: retear rate in the twelve-month postoperative MRI. 
With an estimated retear rate of 30%, with an alpha error 
of 0.05 and a power (1 − β) of 0.5, a total of 31 participants 
for each group were required to detect a difference in retear 
rate between groups of 20%. Accounting for an estimated 
loss of follow-up of 15% a total number of 71 subjects were 
included.
All continuous variables were tested for normality using 
the Kolmogorov–Smirnoff test. Chi-squared test was used 
to compare dichotomous and qualitative variables. Stu-
dent’s T test was used to compare quantitative variables. 
The statistical threshold for significance was established at 
p < 0.05. Two logistic regression analyses were performed 
to assess the possible confounding effect of sex, tear size 
and retraction, and fatty infiltration at the supraspinatus or 
infraspinatus muscles in the retear rate or failure to heal at 
the footprint.
Results
The participant flow can be observed in Fig. 1. From a total 
of 103 subjects assessed for eligibility, 71 were available 
for randomization. All of these were randomized (36 to 
nanofracture and 35 to control) and received the allocated 
intervention. Two subjects (both from the control group) did 
not fulfil the 1 year follow up: one decided that he wanted 
to be withdrawn from the study at the 3 month follow-up 
visit and another did not come to the 1 month visit and was 
lost to follow-up. Recruitment started on January 2017 and 
stopped in May 2018. 
Baseline data
The baseline data for each group can be seen in Table 1. 
There were no significant differences (NS) in any of the 
demographical data, tear characteristics, muscle fatty infil-
tration, surgical technique, associated surgical procedures or 
number of implants used.
Six teams of shoulder surgeons took part in the study 
including 8 shoulder surgeons working in 8 different institu-
tions across Spain (3 public, 3 private and 2 workers’ com-
pensation hospitals). The six teams recruited a median of 6 
participants each (maximum: 42; minimum: 4).
Outcomes and estimation
There were more retears at one-year follow-up in the Con-
trol group (14 retears out of 33 subjects, 42.4%; 95% confi-
dence interval 25.5–60.8%) than in the Nanofracture group 
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(7 out of 36 subjects, (19.4%; 8.2–36.0%; Odds ratio 0.33; 
95% confidence interval 0.11–0.96, p = 0.042). The abso-
lute reduction of retear risk using nanofractures was 0.23 
(0.01–0.44) and the relative reduction of retear risk was 0.46 
(0.21–0.99). When assessed according to the Sugaya clas-
sification there were no significant differences (3.15 [1.23] in 
the control group vs. 2.61 [1.10] in the Nanofracture group 
[n.s].).
When the characteristics of the retear were evaluated 
(whether the tear developed at the musculotendinous junc-
tion or at the footprint), both groups had similar retear rates 
at the musculotendinous junction: 5/33 (15%; 5–32%) in the 
control group and 5/36 (13%, 6–30%) in the Nanofracture 
group (odds ratio: 0.90; 0.24–3.45; n.s.). The nanofracture 
group had better healing rates at the footprint: 24/33 (73%, 
54–87%) healed to the bone in the Control group and 34/36 
(94%, 81–99%) in the nanofracture group (odds ratio 0.16, 
95% confidence interval 0.03–0.79, p = 0.025). The abso-
lute reduction of the retear risk at the footprint using nano-
fractures was 0.21 (0.05–0.38) and the relative reduction of 
retear risk was 0.27 (0.05–0.87).
Pain levels evolved favourably during the twelve-month 
follow up (Table 2). Pain levels improved all along the 
follow-up period. The total constant scores of both groups 
improved significantly compared to the preoperative values 
at the 6-months and 12-months postoperative evaluations 
(p < 0.001, Table 3). All subscales for the constant score 
evolved in a similar pattern. For both parts of the EQ-5D-3L 
(the health index score and the VAS) there were significant 
improvements compared to the preoperative values at the 
six-months and one-year postoperative evaluations (p < 0.01, 
Table 1  Baseline demographic, clinical characteristics and surgical 
data for each group
The number in parenthesis are the standard deviation for quantitative 
variables and the percentage of the total for each group in quantitative 
variables
BMI body mass index, SE supraspinatus, IE infraspinatus, BPI brief 
pain inventory, TTO time trade-off, VAS visual analog score, TOE 




 Age 57.8 (10.7) 60.1 (7.88) n.s.
 Sex (male:female) 18:15 14:22 n.s.
 BMI 28.6 (6.06) 26.7 (3.56) n.s.
Tear size and tendon quality
 Side (left:right) 10:23 14:19 n.s.
 Type n.s.
  Crescent 25 (75.8%) 26 (72.2%)
  L-shaped 4 (12.1%) 5 (13.9%)
  U-shaped 4 (12.1%) 5 (13.9%)
 Tear size 17.6 (5.49) 20.4 (6.4) n.s.
 Tear retraction 15.7 (6.02) 16.5 (6.78) n.s.
 Fatty infiltration
  SE (0:I:II:III) 19:8:3 19:13:4 n.s.
  IE (0:I:II:III) 27:5:1 30:5:1 n.s.
Functional
 Pain levels (BPI) n.s.
  Maximum 7.79 (1.47) 7.94 (1.37)
  Minimum 2.55 (2.09) 3.25 (1.98)
  Mean 5.55 (1.72) 5.83 (1.56)
  Now 5.24 (2.22) 5.81 (2.01)
 Constant score 46.7 (16.3) 42.8 (16.3) n.s.
  Pain 4.21 (3.08) 3.92 (2.83) n.s.
  Functional 9.58 (3.91) 8.72 (3.90) n.s.
  ROM 27.6 (8.80) 25.7 (6.94) n.s.
  Strength 5.29 (6.88) 4.49 (5.73) n.s.
 EQ-5D-3L scores
  Health index (TTO) 0.60 (0.17) 0.59 (0.17)
  Health level (VAS) 61.0 (19.1) 60.7 (20.1)
Surgical technique
 Doble row:TOE 7:26 9:27 n.s.
 Associated procedures n.s.
  Acromioplasty 6 (18.2%) 4 (11.1%)
  Biceps tenotomy 23 (69.7%) 25 (69.4%)
  Biceps tenodesis 1 (3.0%) 1 (2.8%)
  Mumford 2 (6.0%) 3 (8.3%)
 Number of implants 3.5 (1.20) 3.69 (1.06) n.s.
Fig. 1  CONSORT flow diagram
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Table 4). There were no differences in pain levels, constant 
scores, or quality of life between both groups (nanofracture 
vs. control) at any time.  
The logistic regression analysis confirmed the previous 
findings. After adjusting for age, sex, tear size and muscle 
fatty infiltration the Odds ratio for the effect of nanofractures 
Table 2  Pain levels of both groups during the first year after surgery
The subjects answered four questions of the brief Pain Inventory (that assess verbally pain in a 0 to 10 discrete scale) preoperatively. 1 and 
3 weeks and 2, 3, 6 and 12 months postoperatively. Numbers in brackets are the SD. Pain improved in both groups significatively but did not dif-
fer between groups. There were significant improvements in all variables ( p < 0.05) when comparing the preoperative values with either the 6 
months or one year values
Control group Preoperative 6 months 1 year
Maximum pain 7.8 (1.4) 3.7 (2.4) 1.9 (2.5)
Mean pain 2.6 (2.1) 0.8 (1.8) 0.7 (1.6)
Minimum pain 5.6 (1.7) 1.9 (2.2) 1.3 (2.1)
Pain Now 5.2 (2.2) 1.4 (2.2) 1 (1.8)
Nanofracture group Preoperative 6 months 1 year
Maximum pain 7.9 (1.4) 2.4 (2.3) 1.6 (2.4)
Minimum pain 3.2 (2.0) 0.4 (0.9) 0.2 (0.7)
Mean pain 5.8 (1.6) 1.3 (1.6) 0.9 (1.6)
Pain Now 5.8 (2.0) 0.7 (1.3) 0.5 (1.6)
Table 3  Total constant score (and subscales) of both groups preoperatively, 6 and 12 months postoperatively
The total constant score and all the subscales improved in both groups significatively. Starting at the six-months follow-up visit but did not differ 
between groups. Numbers in brackets are the SD. There were significant improvements in all variables (p < 0.05) when comparing the preopera-
tive values with either the 6 months or one year values
Control group Preoperative 6 months 1 year
Pain 4.2 (3.1) 9.7 (3.7) 12.1 (4)
ADL 9.6 (3.9) 15.4 (5.3) 17.2 (4.9)
ROM 27.6 (8.8) 34.8 (9.8) 35.5 (9.8)
Strength 5.3 (6.9) 8.9 (7.4) 12.1 (7.8)
Total constant score 46.7 (16.3) 68.3 (21.9) 76.2 (24.1)
Nanofracture group Preoperative 6 months 1 year
Pain 3.9 (2.8) 11.2 (3.5) 13.2 (2.7)
ADL 8.7 (3.9) 16.7 (3.5) 18.3 (2.4)
ROM 25.7 (6.9) 35.3 (5.6) 38.3 (2.5)
Strength 4.5 (5.7) 10.9 (6.9) 14.8 (7)
Total constant score 42.8 (14.7) 74.1(15) 84.6 (11.8)
Table 4  Outcomes of the EQ- of both groups preoperatively, at 6 and 12 months postoperatively
The health index (calculated by the time trade-off system) and the VAS data are presented. Both the health index and the VAS score improved 
in both groups significatively in all postoperative measures. But did not differ between treatment groups. Numbers in brackets are the SD. There 
were significant improvements in all variables (p < 0.05) when comparing the preoperative values with either the 6 months or one year values
Control group Preoperative 6 months 1 year
Health index (TTO) 0.6 (0.17) 0.86 (0.21) 0.89 (0.19)
VAS 61 (20) 72 (17) 79 (16)
Nanofracture Group Preoperative 6 months 1 year
Health index (TTO) 0.59 (0.17) 0.85 (0.13) 0.88 (0.09)
VAS 61 (19) 72 (20) 78 (21)
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on retear rates was 0.15 (95% confidence interval 0.03–0.63, 
p = 0.009). For failure to heal to the bone the odds ratio was 
0.09 (95% confidence interval 0.01–0.64, p = 0.016).
Harms
No significant complications developed in the Control group 
during the study. Three complications were noted in the 
nanofracture group (n.s.). In one case a trabecular fracture 
developed during implant insertion that required a change 
in position of the implant but did not preclude a satisfactory 
repair. This subject eventually developed a re-rupture at the 
musculotendinous junction with a final constant score of 
86. Two participants presented with swelling and pain at 
the shoulder at the one-week follow-up and the suspicion 
of an infection was established. In the first case the prob-
lem was mild and a 1-week course of oral antibiotics solved 
the symptoms, the tendon healed successfully and the final 
constant score was 87. In the second case, a deep infec-
tion was suspected, and an arthroscopic lavage of the joint 
was performed followed by a 10-day course of intravenous 
antibiotics. Intraoperative cultures were negative, the sub-
ject improved, the tendon healed successfully, and the final 
constant score was 95.
Discussion
The main finding of this study is that adding nanofractures 
to the footprint of a mid-size suprapinatus tear repaired with 
a double row or transosseous equivalent technique increases 
the chances of healing of the tendon when assessed with 
MRI at 12-months follow-up. These increased healing 
chances seem to be due to increased healing at the foot-
print, but the retear rate at the musculotendinous junction 
does not vary.
Different previous RCT have looked for evidence of 
the efficacy of bone marrow stimulation with microfrac-
tures. Milano et al. [14] and Osti et al. [15] performed two 
randomized controlled trials to evaluate the efficacy of 
microfractures (done with an arthroscopic awl that created 
1.5–2 mm wide, 3–5 mm deep, holes) at the footprint dur-
ing rotator cuff repair but did not find differences in struc-
tural healing (evaluated with MRI) or functional outcomes 
at 1 year. Jo et al. [12], in a lower quality cohort study, did 
find differences in the retear rate when performing micro-
fractures (with a 2 mm × 10 mm bone punch): they found 
retear rates similar to our study with 22% retear rate in the 
microfracture group and 45% in the control group. Taigu-
chi et al. [18] in a retrospective cohort study also found 
differences with retear rates in the microfracture group of 
9% and 24% in the control group, the microfractures were 
performed with an 3 mm-arthroscopic awl. To summarize 
this data, Arjawat et al. [2] made a meta-analysis of these 
four studies and found that microfractures decreased in 
half the chances of finding a re-tear at 1 year (odds ratio, 
0.42; 95% confidence interval: 0.25–0.73; p = 0.002). 
Thus, the results of this study seem to fall in line with 
those found by other authors.
One novel information that this study provided is that the 
retear rate at the musculotendinous junction did not seem to 
be affected by the nanofractures, but it did affect the chances 
of healing at the footprint. This makes sense, as nanofrac-
tures should help the tendon-to-bone healing, but cannot 
avoid medial tears.
The functional outcomes and quality of life measures 
improved significantly after surgery in both groups but no 
differences between groups were observed despite the differ-
ences in retear rates. This is partly expected as the associa-
tion between anatomical outcomes and clinical outcomes 
after rotator cuff repair is often weak [16]. For example, in 
the recent meta-analysis by Arjawat et al. [2], no differences 
in clinical outcomes were observed.
In this study, three complications developed in the Nanof-
racture group. None of these affected the clinical outcome. In 
the case where a retear developed after a trabecular fracture 
during implant insertion, the retear developed at the muscu-
lotendinous junction, not at the “fractured” footprint. Two 
other cases developed postoperative swelling with negative 
cultures. These might be related to some degree of increased 
early postoperative inflammation of the shoulder due to the 
increased insult to the bone during microfracturing.
There are some limitations to this study. A first limita-
tion is that eight different surgeons performed the surgical 
procedures, and these was indeed some variability of the 
techniques uses, this could add relevant variability to the 
study. Despite this, an adequate choice of comparator, good 
blinding, similar expertise of the surgeons, strict randomiza-
tion and a well-powered study allowed for the valid result 
to be obtained. Another limitation is that a single team of 
surgeons performed most of the cases (42 of 71 participants 
assessed for outcomes), this could limit the generalizability 
of the results. Despite this, the team included three different 
surgeons that worked in a large University hospital and a pri-
vate practice centre, so the diversity of the subjects included 
was still high. The last limitation is that, when performing 
sample size calculation, a power of only 0.5 was selected to 
limit the sample size to something feasible (using an optimal 
0.90 power would require over 200 participants).
The results obtained here can be generalized to the gen-
eral population with midsize supraspinatus tears. The varied 
origin of the subjects included (coming form 8 centers in 6 
cities around Spain and including private patients, national 
health service patients and worker compensation patients) 
assures that the results could be extrapolated to the general 
population.
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Conclusions
Adding nanofractures at the footprint during an iso-
lated supraspinatus repair lowers in half the retear rate at 
12-months follow-up. This is due to improved healing at 
the footprint.
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A full copy (in Spanish) of the IRB-approved protocol can 
be seen in Online Appendix 1.
A full copy (in Spanish) of the CRD can be seen in Online 
Appendix 2.
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